Showing results (231-240 of 1,273) with videos related to

Sort By:
Pageof 128
Clinical Colorectal Cancer|June 3, 2023
Differential Efficacy of Targeted Monoclonal Antibodies in Left-Sided Colon and Rectal Metastatic CancersHiroyuki Kodama, Toshiki Masuishi, Munehiro Wakabayashi, et al.
Clinical Colorectal Cancer|June 3, 2023
Preoperative Radiotherapy Decision-Tree for Rectal Cancer Patients: A Real-World Analysis Based on the Swedish Colorectal Cancer RegistryBin Luo, Chuanwen Fan, Xuqin Xie, et al.
Clinical Colorectal Cancer|May 27, 2026
Detection of Polyps in Colon Capsule Endoscopy and Impact of Colonic Transit TimeOla Selnes, Lea Østergaard Hansen, Benedicte Schelde-Olesen, et al.
Clinical Colorectal Cancer|February 13, 2026
Randomized phase III Study of Adding Paclitaxel to Chemoradiotherapy With Capecitabine and Mitomycin C in Squamous Cell Anal CarcinomaSergey S Gordeyev, Marina V Chernykh, Mikhail Yu Fedyanin, et al.
Clinical Colorectal Cancer|March 4, 2026
Phase Ib Study to Assess the Safety of Neoadjuvant Trifluridine/Tipiracil With Concurrent Radiation in Resectable Stage II/III Rectal Cancer: The FIERCE StudyEmerson Y Chen, Nima Nabavizadeh, Nicholas D Kendsersky, et al.
Clinical Colorectal Cancer|February 18, 2026
Brain Metastasis From Anal Canal Squamous Cell Carcinoma: A Rare Case Report and Systematic ReviewMiriam Tomaciello, Mauro Palmieri, Massimo Corsini, et al.
Clinical Colorectal Cancer|June 9, 2024
Brazil-TNT: A Randomized Phase 2 Trial of Neoadjuvant Chemoradiation Followed by FOLFIRINOX Versus Chemoradiation for Stage II/III Rectal CancerDiogo Diniz Gomes Bugano, Vanessa Montes Santos, Arinilda Campos-Bragagnoli, et al.
Clinical Colorectal Cancer|December 17, 2016
Perioperative Triplet Chemotherapy and Cetuximab in Patients With RAS Wild Type High Recurrence Risk or Borderline Resectable Colorectal Cancer Liver MetastasesFilippo Pietrantonio, Maria Di Bartolomeo, Christian Cotsoglou, et al.
Clinical Colorectal Cancer|October 14, 2009
Improved patient and regimen selection in locally advanced rectal cancer: who, how, and what next?Jared Weiss, Drew Moghanaki, John P Plastaras, et al.
Clinical Colorectal Cancer|October 14, 2009
Toxicity and efficacy of 5-fluorouracil and capecitabine in a patient with TYMS gene polymorphism: A challenge or a dilemma?Armin Shahrokni, Mohammad Reza Rajebi, Muhammad Wasif Saif
Pageof 128